Mutation found that may provide protection against Alzheimer’s disease Immunity: M28L mutation in the PLCG2 gene reduces the risk of Alzheimer’s disease in mice 09.17.2023, 22:45

Scientists from Stanford University have discovered a mutation in the PLCG2 gene that may reduce the risk of Alzheimer’s disease. The authors of the discovery believe that it affects the functioning of immune cells in the brain, proving that Alzheimer’s disease is an immune disease. The research was published in the journal Immunity.

Alzheimer’s disease is a neurodegenerative disease affecting the elderly, whose symptoms are associated with the buildup of aggregates (plaques) of the beta-amyloid protein. Recent research has shown that dementia causes chronic inflammation in the brain. Therefore, the authors of the new study suggested that the development of Alzheimer’s disease may be associated with mutations in immune cells.

To test the hypothesis, scientists tested different variants of the PLCG2 gene in mice. This gene is known to be active in immune cells (microglia) that detect and destroy germs or unhealthy cells in the brain.

When scientists removed this gene from the DNA of mice, they found that they were more likely to develop Alzheimer’s disease. This was because microglia lost their normal ability to respond to amyloid deposits.

Mutations in this gene had different effects on dementia risk. The M28L mutation in the PLCG2 gene also prevented microglia from responding to amyloid plaques, increasing the likelihood of the disease. But another version of the gene, P522R, in contrast, boosted the working memory of mice, a model of Alzheimer’s disease.

Although the M28L mutation is seen in humans, there is no evidence that it has a protective effect in humans. But the new study is consistent with recent suggestions that Alzheimer’s disease is an immune disease and that the amyloid plaques themselves are not the cause of the symptoms.

Scientists suggest that treatments aimed at stimulating microglia to fight amyloid plaques could limit the progression of Alzheimer’s disease.

Previous scientists I learnedHe showed that treating immunotherapy cells with vitamin B3 could increase their ability to kill cancer.

Source: Gazeta


More from author

The White House announced what the basis of Ukraine negotiations should be 19:50

The United States believes that the basis for any negotiations regarding Ukraine must be acceptable to Kiev. This was stated by White House...

Oil prices are approaching July lows 19:52

The barrel price of Brent oil fell below $75 for the first time since July 6, 2023. This is evidenced by trading data...

The first details became clear after the examination of the body of the former deputy of Kiva Rada 19:43

An unknown person shot at former Verkhovna Rada deputy Ilya Kiva. This has been reported telegram channel Investigative Directorate of the Investigative Committee...

The 200th plane carrying military cargo from the USA arrived in Israel 17:32

The 200th American cargo plane carrying military aid arrived in Israel. This was reported by TASS referring to the Israeli military department. “The Israeli...